Preferential increase in subendocardial perfusion produced by endothelium-dependent vasodilators

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Myocardial Blood Flow Dynamics

Background:

• Understanding myocardial blood flow distribution is crucial for diagnosing and treating cardiac conditions.
• Endothelium-dependent vasodilators play a key role in regulating coronary circulation.
• The precise mechanisms by which these agents affect transmural flow, particularly to the subendocardium, require further elucidation.

Purpose of the Study:

• To investigate the transmural distribution of myocardial blood flow during intracoronary infusion of various vasodilators.
• To determine the role of phospholipase A2 in mediating the effects of endothelium-dependent vasodilators on subendocardial perfusion.
• To compare the actions of endothelium-dependent vasodilators with an endothelium-independent vasodilator.

Main Methods:

• Radioactive microspheres were used to measure transmural myocardial blood flow in anesthetized dogs.
• Intracoronary infusions of acetylcholine, adenosine triphosphate (ATP), arachidonic acid, and nifedipine were administered.
• The effects of these infusions were assessed before and after intracoronary administration of the phospholipase A2 inhibitor, quinacrine.

Main Results:

• Acetylcholine, ATP, and arachidonic acid significantly increased overall myocardial blood flow and the subendocardial to subepicardial flow ratio (endo/epi).
• Quinacrine did not alter the baseline endo/epi ratio or block the increase in total blood flow but did inhibit the preferential increase in subendocardial flow.
• Nifedipine, an endothelium-independent vasodilator, did not affect the endo/epi ratio, even after quinacrine administration.

Conclusions:

• Endothelium-dependent vasodilators promote a preferential increase in subendocardial perfusion.
• This preferential flow appears to be mediated by a product of unsaturated fatty acid metabolism, likely involving phospholipase A2.
• The findings highlight a specific mechanism for enhancing blood supply to the critical subendocardial region of the left ventricle.